Dr. Schwarze received a Ph.D. in Molecular Biology at the University of Wisconsin-Madison in 1998. Over the next six years he furthered his education with post-doctoral training, conducting research at Washington University (Howard Hughes Medical Institute) in St. Louis and at the University of Wisconsin Comprehensive Cancer Center. In 2005 he became a faculty member at the University of Kentucky Markey Cancer Center. After being in the research field for 20 years, Dr. Schwarze obtained training as a Medical Laboratory Scientist in 2011 and earned professional certification in 2012. Dr. Schwarze joined the Medical Laboratory Science Program at the University of Kentucky in 2013 as an Assistant Professor.
Dr. Schwarze teaches Clinical Immunology, Immunohematology (Blood Banking and Transfusion Medicine), and Molecular Diagnostics.
Dr. Schwarze has an adjunct appointment in the Department of Pathology. His main area of interest is the molecular analysis of human tumor specimens. In the clinical laboratory, he oversees development, validation, and implementation of fluorescent in-situ hybridization (FISH) testing in solid tumors. The results of these assays are integral for directing patient treatment of breast and lung cancer, and the diagnosis and prognosis of other tumor types. Dr. Schwarze’s research interests address how various molecular alterations are associated with diagnosis, prognosis and progression of brain cancer and other solid tumor types.